special purpose acquisition company

The merger with the special-purpose acquisition company Social Capital Suvretta Holdings Corp. I is expected to net Akili up to $412 million.

The prescription digital therapeutics company said the transaction generated approximately $175 million.

Pear announced plans to go public through a merger with a special purpose acquisition company in June, and the deal is set to close soon.

Science 37 will have an initial enterprise value of approximately $1.05 billion.   

The prospect of companies hitting the public markets before they’re fully prepared creates the possibility for failure, according to Rock Health.  

Investment firm Kuwait Life Sciences Company's Dr. Mussaad M. Al-Razouki gives a breakdown of recently filed or finalized digital health SPACs, as well as a list of unicorns ripe for a potential merger.

The company currently sells connected wearables and smart monitors to consumers, but said that it will be seeking FDA authorization for new products with broader indications and telehealth capabilities down the line.

The deal values 23andMe at approximately $3.5 billion through the combination of stock and cash financing.  

The deal rates Clover at an enterprise value of about $3.7 billion and is expected to close in early 2021.